Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 1004.e17-1004.e20

  Van Langenhove, Tim ^a,b,c   Van der Zee, Julie ^a,b   Engelborghs, Sebastiaan ^b,d,e   Vandenberghe, Rik ^f   Santens, Patrick ^g   Van den Broeck, Marleen ^a,b   Mattheijssens, Maria ^a,b   Peeters, Karin ^a,b   Nuytten, Dirk ^h   Cras, Patrick ^b,c   De Deyn, Peter P ^b,d,e   De Jonghe, Peter ^a,b,c   Cruts, Marc ^a,b   Van Broeckhoven, Christine ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d Hospital Network Antwerp (ZNA) Middelheim   (Belgium)

^e Memory Clinic   (Belgium)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h Stuivenberg General Hospital   (Belgium)

Author keywords

ATXN2; FTLD ALS disease spectrum; Genetics; Genotype phenotype correlations; Sca 2

Indexed keywords

POLYGLUTAMINE;

ADULT; AGED; ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATAXIN 2 GENE; BELGIUM; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SPINOCEREBELLAR ATAXIA TYPE 2; SPINOCEREBELLAR DEGENERATION;

EID: 85058205420     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.09.025     Document Type: Article

References (14)

1. Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., Padmanabhan A., Clay-Falcone D., McCluskey L., Elman L., Juhr D., Gruber P.J., Rüb U., Auburger G., Trojanowski J.Q., Lee V.M.-Y., Van Deerlin V.M., Bonini N.M., Gitler A.D. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010, 466:1069-1075.
2. Fernandez M., McClain M.E., Martinez R.A., Snow K., Lipe H., Ravits J., Bird T.D., La Spada A.R. Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology 2000, 55:569-572.
3. Gwinn-Hardy K., Chen J.Y., Liu H.C., Liu T.Y., Boss M., Seltzer W., Adam A., Singleton A., Koroshetz W., Waters C., Hardy J., Farrer M. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000, 55:800-805.
4. Imbert G., Saudou F., Yvert G., Devys D., Trottier Y., Garnier J.M., Weber C., Mandel J.L., Cancel G., Abbas N., Dürr A., Didierjean O., Stevanin G., Agid Y., Brice A. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat. Genet. 1996, 14:285-291.
5. Infante J., Berciano J., Volpini V., Corral J., Polo J.M., Pascual J., Combarros O. Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease. Mov. Disord. 2004, 19:848-852.
6. Lee T., Li Y.R., Ingre C., Weber M., Grehl T., Gredal O., de Carvalho M., Meyer T., Tysnes O.-B., Auburger G., Gispert S., Bonini N.M., Andersen P.M., Gitler A.D. Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum. Mol. Genet. 2011, 20:1697-1700.
7. Lomen-Hoerth C., Anderson T., Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002, 59:1077-1079.
8. Mackenzie I.R.A., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010, 9:995-1007.
9. Morita M., Al-Chalabi A., Andersen P.M., Hosler B., Sapp P., Englund E., Mitchell J.E., Habgood J.J., de Belleroche J., Xi J., Jongjaroenprasert W., Horvitz H.R., Gunnarsson L.-G., Brown R.H. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006, 66:839-844.
10. Nanetti L., Fancellu R., Tomasello C., Gellera C., Pareyson D., Mariotti C. Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J. Neurol. 2009, 256:1926-1928.
11. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R.A., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M.-Y. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
12. Ross O.A., Rutherford N.J., Baker M., Soto-Ortolaza A.I., Carrasquillo M.M., Dejesus-Hernandez M., Adamson J., Li M., Volkening K., Finger E., Seeley W.W., Hatanpaa K.J., Lomen-Hoerth C., Kertesz A., Bigio E.H., Lippa C., Woodruff B.K., Knopman D.S., White C.L., Van Gerpen J.A., Meschia J.F., Mackenzie I.R., Boylan K., Boeve B.F., Miller B.L., Strong M.J., Uitti R.J., Younkin S.G., Graff-Radford N.R., Petersen R.C., Wszolek Z.K., Dickson D.W., Rademakers R. Ataxin-2 repeat-length variation and neurodegeneration. Hum. Mol. Genet. 2011, 20:3207-3212.
13. van Es M.A., Veldink J.H., Saris C.G.J., Blauw H.M., van Vught P.W.J., Birve A., Lemmens R., Schelhaas H.J., Groen E.J.N., Huisman M.H.B., van der Kooi A.J., de Visser M., Dahlberg C., Estrada K., Rivadeneira F., Hofman A., Zwarts M.J., van Doormaal P.T.C., Rujescu D., Strengman E., Giegling I., Muglia P., Tomik B., Slowik A., Uitterlinden A.G., Hendrich C., Waibel S., Meyer T., Ludolph A.C., Glass J.D., Purcell S., Cichon S., Nöthen M.M., Wichmann H.-E., Schreiber S., Vermeulen S.H.H.M., Kiemeney L.A., Wokke J.H.J., Cronin S., McLaughlin R.L., Hardiman O., Fumoto K., Pasterkamp R.J., Meininger V., Melki J., Leigh P.N., Shaw C.E., Landers J.E., Al-Chalabi A., Brown R.H., Robberecht W., Andersen P.M., Ophoff R.A., van den Berg L.H. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009, 41:1083-1087.
14. Velázquez Pérez L., Cruz G.S., Santos Falcón N., Almaguer Mederos E.L., Escalona Batallan K., Rodríguez Labrada R., Paneque Herrera M., Laffita Mesa J.M., Rodríguez Díaz J.C., Rodríguez R.A., González Zaldivar Y., Coello Almarales D., Almaguer Gotay D., Jorge Cedeño H. Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguín. Neurosci. Lett. 2009, 454:157-160.